id
stringlengths 11
11
| tags
stringlengths 10
777
| text
stringlengths 2
1.5k
| dataset_num
int64 1
3
| tokens
list | ner_tags
list |
|---|---|---|---|---|---|
NCT02493530
|
,60:85:treatment
|
Recovery to ≤ Grade 1 or baseline of any toxicities due to prior systemic treatments
| 1
|
[
"Recovery",
"to",
"≤",
"Grade",
"1",
"or",
"baseline",
"of",
"any",
"toxicities",
"due",
"to",
"prior",
"systemic",
"treatments"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1
] |
NCT02547662
|
,,146:160:treatment
|
Diarrhea > grade 1, based on the National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) grading, in the absence of antidiarrheals
| 1
|
[
"Diarrhea",
">",
"grade",
"1",
",",
"based",
"on",
"the",
"National",
"Cancer",
"Institute",
"Common",
"Terminology",
"Criteria",
"for",
"Adverse",
"Events",
"(",
"NCI",
"CTCAE",
")",
"grading",
",",
"in",
"the",
"absence",
"of",
"antidiarrheals"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02169089
|
18:28:cancer,39:47:cancer,52:60:cancer
|
History of prior malignancy including leukemia and lymphoma
| 1
|
[
"History",
"of",
"prior",
"malignancy",
"including",
"leukemia",
"and",
"lymphoma"
] |
[
0,
0,
0,
3,
0,
3,
0,
3
] |
NCT01345344
|
16:33:treatment,37:58:treatment,90:101:chronic_disease,123:132:treatment
|
current use of opioid analgesics or stimulant medications or the fatigue associated with sleep apnea or shift work (e.g., modafinil)
| 1
|
[
"current",
"use",
"of",
"opioid",
"analgesics",
"or",
"stimulant",
"medications",
"or",
"the",
"fatigue",
"associated",
"with",
"sleep",
"apnea",
"or",
"shift",
"work",
"(",
"e.g.",
",",
"modafinil",
")"
] |
[
0,
0,
0,
1,
1,
0,
1,
1,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
1,
0
] |
NCT02314377
|
37:54:chronic_disease,56:84:chronic_disease,89:112:chronic_disease,
|
Patients must not have a history of abdominal fistula, gastrointestinal perforation, or intra-abdominal abscess within 6 months prior to study enrollment
| 1
|
[
"Patients",
"must",
"not",
"have",
"a",
"history",
"of",
"abdominal",
"fistula",
",",
"gastrointestinal",
"perforation",
",",
"or",
"intra-abdominal",
"abscess",
"within",
"6",
"months",
"prior",
"to",
"study",
"enrollment"
] |
[
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
2,
2,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT03030859
|
1:25:chronic_disease
|
congestive heart failure
| 1
|
[
"congestive",
"heart",
"failure"
] |
[
2,
2,
2
] |
NCT01591356
|
20:36:treatment,46:61:cancer,68:78:treatment,82:127:treatment
|
stable regimens of hormonal therapy i.e. for prostate cancer (e.g. leuprolide, a gonadotropin-releasing hormone [GnRH] agonist)
| 1
|
[
"stable",
"regimens",
"of",
"hormonal",
"therapy",
"i.e",
".",
"for",
"prostate",
"cancer",
"(",
"e.g",
".",
"leuprolide",
",",
"a",
"gonadotropin-releasing",
"hormone",
"[",
"GnRH",
"]",
"agonist",
")"
] |
[
0,
0,
0,
1,
1,
0,
0,
0,
3,
3,
0,
0,
0,
1,
0,
0,
1,
1,
1,
1,
0,
0,
0
] |
NCT03007030
|
13:26:treatment
|
Any line of prior therapy
| 1
|
[
"Any",
"line",
"of",
"prior",
"therapy"
] |
[
0,
0,
0,
1,
1
] |
NCT02101736
|
1:4:chronic_disease
|
HIV testing will not be required as part of this trial, unless HIV is clinically suspected
| 1
|
[
"HIV",
"testing",
"will",
"not",
"be",
"required",
"as",
"part",
"of",
"this",
"trial",
",",
"unless",
"HIV",
"is",
"clinically",
"suspected"
] |
[
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02323191
|
1:22:treatment,26:45:treatment,,94:104:treatment
|
Prior corticosteroids as anti-cancer therapy within a minimum of 14 days of first receipt of study drug
| 1
|
[
"Prior",
"corticosteroids",
"as",
"anti-cancer",
"therapy",
"within",
"a",
"minimum",
"of",
"14",
"days",
"of",
"first",
"receipt",
"of",
"study",
"drug"
] |
[
1,
1,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT01349101
|
19:23:cancer,27:33:chronic_disease,56:76:treatment
|
For patients with CMML or RAEB-2 they must demonstrate chemo-responsiveness
| 1
|
[
"For",
"patients",
"with",
"CMML",
"or",
"RAEB-2",
"they",
"must",
"demonstrate",
"chemo-responsiveness"
] |
[
0,
0,
0,
3,
0,
2,
0,
0,
0,
1
] |
NCT02046330
|
56:88:treatment
|
Any clinically significant abnormality on preoperative magnetic resonance imaging (MRI)
| 1
|
[
"Any",
"clinically",
"significant",
"abnormality",
"on",
"preoperative",
"magnetic",
"resonance",
"imaging",
"(",
"MRI",
")"
] |
[
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
0,
0
] |
NCT02213913
|
12:22:cancer,,129:153:cancer,179:196:cancer
|
No current malignancy. Subjects who have been free of malignancy for at least 2 years, or have a history of completely resected non-melanoma skin cancer, or successfully treated in situ carcinoma (any site) are eligible
| 1
|
[
"No",
"current",
"malignancy",
".",
"Subjects",
"who",
"have",
"been",
"free",
"of",
"malignancy",
"for",
"at",
"least",
"2",
"years",
",",
"or",
"have",
"a",
"history",
"of",
"completely",
"resected",
"non-melanoma",
"skin",
"cancer",
",",
"or",
"successfully",
"treated",
"in",
"situ",
"carcinoma",
"(",
"any",
"site",
")",
"are",
"eligible"
] |
[
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
0,
0,
0,
0,
3,
3,
3,
0,
0,
0,
0,
0,
0
] |
NCT01917721
|
45:56:treatment
|
Patients whose parents refuse to administer doxycycline
| 1
|
[
"Patients",
"whose",
"parents",
"refuse",
"to",
"administer",
"doxycycline"
] |
[
0,
0,
0,
0,
0,
0,
1
] |
NCT01690468
|
31:43:treatment
|
At least one prior regimen of chemotherapy, with no maximum number of chemotherapy cycles
| 1
|
[
"At",
"least",
"one",
"prior",
"regimen",
"of",
"chemotherapy",
",",
"with",
"no",
"maximum",
"number",
"of",
"chemotherapy",
"cycles"
] |
[
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02891850
|
1:19:chronic_disease,21:56:chronic_disease
|
orthopedic disease, peripheral artery occlusive disease, which affects the patient's ability to walk
| 1
|
[
"orthopedic",
"disease",
",",
"peripheral",
"artery",
"occlusive",
"disease",
",",
"which",
"affects",
"the",
"patient",
"'s",
"ability",
"to",
"walk"
] |
[
2,
2,
0,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02106988
|
13:16:chronic_disease
|
known to be HIV positive
| 1
|
[
"known",
"to",
"be",
"HIV",
"positive"
] |
[
0,
0,
0,
2,
0
] |
NCT02877394
|
16:32:treatment,39:52:treatment,54:67:treatment,69:80:treatment
|
Current use of anticholinergics (e.g. nortriptyline, amitriptyline, hyoscyamine)
| 1
|
[
"Current",
"use",
"of",
"anticholinergics",
"(",
"e.g",
".",
"nortriptyline",
",",
"amitriptyline",
",",
"hyoscyamine",
")"
] |
[
0,
0,
0,
1,
0,
0,
0,
1,
0,
1,
0,
1,
0
] |
NCT02863809
|
1:20:chronic_disease
|
Autoimmune diseases
| 1
|
[
"Autoimmune",
"diseases"
] |
[
2,
2
] |
NCT02273375
|
82:86:cancer,88:94:cancer,96:102:cancer,107:112:cancer
|
according to WHO Classification of Tumours (WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart. WHO/IARC Classification of Tumours, 4th Edition, Volume 7)
| 1
|
[
"according",
"to",
"WHO",
"Classification",
"of",
"Tumours",
"(",
"WHO",
"Classification",
"of",
"Tumours",
"of",
"the",
"Lung",
",",
"Pleura",
",",
"Thymus",
"and",
"Heart",
".",
"WHO/IARC",
"Classification",
"of",
"Tumours",
",",
"4th",
"Edition",
",",
"Volume",
"7",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
0,
3,
0,
3,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02588612
|
51:61:cancer
|
Subjects must be in complete remission from prior malignancy in order to be eligible to enter the study
| 1
|
[
"Subjects",
"must",
"be",
"in",
"complete",
"remission",
"from",
"prior",
"malignancy",
"in",
"order",
"to",
"be",
"eligible",
"to",
"enter",
"the",
"study"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02109627
|
1:23:chronic_disease
|
Uncontrolled infection
| 1
|
[
"Uncontrolled",
"infection"
] |
[
2,
2
] |
NCT02983903
|
1:18:chronic_disease
|
Bullous emphysema in region of nodule
| 1
|
[
"Bullous",
"emphysema",
"in",
"region",
"of",
"nodule"
] |
[
2,
2,
0,
0,
0,
0
] |
NCT02382549
|
1:14:treatment
|
MEK inhibitor
| 1
|
[
"MEK",
"inhibitor"
] |
[
1,
1
] |
NCT02343549
|
11:21:cancer
|
localized basal cell
| 1
|
[
"localized",
"basal",
"cell"
] |
[
0,
3,
3
] |
NCT02353819
|
10:17:treatment,21:33:treatment,38:53:cancer
|
Previous surgery or chemotherapy for prostate cancer
| 1
|
[
"Previous",
"surgery",
"or",
"chemotherapy",
"for",
"prostate",
"cancer"
] |
[
0,
1,
0,
1,
0,
3,
3
] |
NCT02555189
|
1:8:treatment,14:21:treatment,23:58:treatment,62:74:treatment
|
Therapy with heparin, low molecular weight heparin (LMWH) or fondaparinux
| 1
|
[
"Therapy",
"with",
"heparin",
",",
"low",
"molecular",
"weight",
"heparin",
"(",
"LMWH",
")",
"or",
"fondaparinux"
] |
[
1,
0,
1,
0,
1,
1,
1,
1,
1,
0,
0,
0,
1
] |
NCT02350764
|
23:26:chronic_disease
|
Any positive test for HIV
| 1
|
[
"Any",
"positive",
"test",
"for",
"HIV"
] |
[
0,
0,
0,
0,
2
] |
NCT02340156
|
,,73:83:treatment
|
Have diastolic blood pressure of > 90 mm Hg resting at baseline despite medication
| 1
|
[
"Have",
"diastolic",
"blood",
"pressure",
"of",
">",
"90",
"mm",
"Hg",
"resting",
"at",
"baseline",
"despite",
"medication"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT01918644
|
30:68:cancer
|
Patients with no evidence of regional or distant metastatic disease based on CT scan of the chest/ abdomen/pelvis
| 1
|
[
"Patients",
"with",
"no",
"evidence",
"of",
"regional",
"or",
"distant",
"metastatic",
"disease",
"based",
"on",
"CT",
"scan",
"of",
"the",
"chest/",
"abdomen/pelvis"
] |
[
0,
0,
0,
0,
0,
3,
3,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02826577
|
47:72:chronic_disease
|
Meet MINI criteria for anything but untreated major depressive disorder
| 1
|
[
"Meet",
"MINI",
"criteria",
"for",
"anything",
"but",
"untreated",
"major",
"depressive",
"disorder"
] |
[
0,
0,
0,
0,
0,
0,
0,
2,
2,
2
] |
NCT01992861
|
15:59:cancer
|
Patients with small cell/neuroendocrine cervical carcinoma
| 1
|
[
"Patients",
"with",
"small",
"cell/neuroendocrine",
"cervical",
"carcinoma"
] |
[
0,
0,
3,
3,
3,
3
] |
NCT02877381
|
73:76:allergy_name
|
Patients scheduled for a head and liner/poly exchange, known allergy to TXA, acquired disturbances of color vision, refusal of blood products
| 1
|
[
"Patients",
"scheduled",
"for",
"a",
"head",
"and",
"liner/poly",
"exchange",
",",
"known",
"allergy",
"to",
"TXA",
",",
"acquired",
"disturbances",
"of",
"color",
"vision",
",",
"refusal",
"of",
"blood",
"products"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
4,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02826681
|
1:23:chronic_disease,,,,,,,
|
Iron-deficiency anemia defined as an Hgb <12 g/dl with a ferritin <20 ng/mL, or ferritin <100 when TSAT is <18%
| 1
|
[
"Iron-deficiency",
"anemia",
"defined",
"as",
"an",
"Hgb",
"<",
"12",
"g/dl",
"with",
"a",
"ferritin",
"<",
"20",
"ng/mL",
",",
"or",
"ferritin",
"<",
"100",
"when",
"TSAT",
"is",
"<",
"18",
"%"
] |
[
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02160288
|
13:31:chronic_disease
|
Presence of fecal incontinence
| 1
|
[
"Presence",
"of",
"fecal",
"incontinence"
] |
[
0,
0,
2,
2
] |
NCT02493257
|
1:19:treatment,
|
Intranasal steroid use >4 wks
| 1
|
[
"Intranasal",
"steroid",
"use",
">",
"4",
"wks"
] |
[
1,
1,
0,
0,
0,
0
] |
NCT02811679
|
22:37:treatment,
|
Therapeutic doses of corticosteroids within 14 days prior to study entry
| 1
|
[
"Therapeutic",
"doses",
"of",
"corticosteroids",
"within",
"14",
"days",
"prior",
"to",
"study",
"entry"
] |
[
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT03121352
|
15:39:cancer
|
Patients with carcinomatous meningitis
| 1
|
[
"Patients",
"with",
"carcinomatous",
"meningitis"
] |
[
0,
0,
3,
3
] |
NCT02359825
|
43:52:treatment,
|
willing to comply with all aspects of the treatment and evaluation schedule over a 12 months period
| 1
|
[
"willing",
"to",
"comply",
"with",
"all",
"aspects",
"of",
"the",
"treatment",
"and",
"evaluation",
"schedule",
"over",
"a",
"12",
"months",
"period"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01589263
|
11:24:treatment,26:41:treatment,43:53:treatment,58:73:treatment,78:100:treatment,
|
Has taken phenylephrine, pseudoephedrine, imipramine, an anticholinergic, or cholinergic medication within the past 2 weeks
| 1
|
[
"Has",
"taken",
"phenylephrine",
",",
"pseudoephedrine",
",",
"imipramine",
",",
"an",
"anticholinergic",
",",
"or",
"cholinergic",
"medication",
"within",
"the",
"past",
"2",
"weeks"
] |
[
0,
0,
1,
0,
1,
0,
1,
0,
0,
1,
0,
0,
1,
1,
0,
0,
0,
0,
0
] |
NCT02577549
|
33:52:chronic_disease
|
Knee Pain plus ACR Criteria for Knee Osteoarthritis
| 1
|
[
"Knee",
"Pain",
"plus",
"ACR",
"Criteria",
"for",
"Knee",
"Osteoarthritis"
] |
[
2,
2,
0,
0,
0,
0,
0,
0
] |
NCT02367040
|
32:44:treatment,,118:137:treatment,127:136:treatment,,312:342:treatment
|
be considered unfit to receive chemotherapy on reason of age, concomitant morbidities, and/or residual toxicity from previous treatments, or unwillingness to receive chemotherapy. These patients must also have had a progression-free and treatment-free interval of at least 6 months after completion of the last rituximab-containing treatment. Patients in whom chemotherapy is contraindicated are defined by one of the following features
| 1
|
[
"be",
"considered",
"unfit",
"to",
"receive",
"chemotherapy",
"on",
"reason",
"of",
"age",
",",
"concomitant",
"morbidities",
",",
"and/or",
"residual",
"toxicity",
"from",
"previous",
"treatments",
",",
"or",
"unwillingness",
"to",
"receive",
"chemotherapy",
".",
"These",
"patients",
"must",
"also",
"have",
"had",
"a",
"progression-free",
"and",
"treatment-free",
"interval",
"of",
"at",
"least",
"6",
"months",
"after",
"completion",
"of",
"the",
"last",
"rituximab-containing",
"treatment",
".",
"Patients",
"in",
"whom",
"chemotherapy",
"is",
"contraindicated",
"are",
"defined",
"by",
"one",
"of",
"the",
"following",
"features"
] |
[
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02415660
|
16:33:chronic_disease,43:70:treatment,75:78:treatment,110:122:chronic_disease,124:142:chronic_disease,146:170:treatment
|
History of any systemic disorder in which thoracic spine manipulation and TDN would be contraindicated (i.e. osteoporosis, bleeding disorders or anticoagulant medication use)
| 1
|
[
"History",
"of",
"any",
"systemic",
"disorder",
"in",
"which",
"thoracic",
"spine",
"manipulation",
"and",
"TDN",
"would",
"be",
"contraindicated",
"(",
"i.e",
".",
"osteoporosis",
",",
"bleeding",
"disorders",
"or",
"anticoagulant",
"medication",
"use",
")"
] |
[
0,
0,
0,
2,
2,
0,
0,
1,
1,
1,
0,
1,
0,
0,
0,
0,
0,
0,
2,
0,
2,
2,
0,
1,
1,
0,
0
] |
NCT02305537
|
24:33:chronic_disease
|
those who are actively psychotic
| 1
|
[
"those",
"who",
"are",
"actively",
"psychotic"
] |
[
0,
0,
0,
0,
2
] |
NCT02004275
|
,,,,199:211:treatment
|
Must have a negative serum or urine pregnancy test with a sensitivity of at least 25 mlU/ml no more than 14 days prior to registration and must agree to repeat this test within 24 hours of starting pomalidomide
| 1
|
[
"Must",
"have",
"a",
"negative",
"serum",
"or",
"urine",
"pregnancy",
"test",
"with",
"a",
"sensitivity",
"of",
"at",
"least",
"25",
"mlU/ml",
"no",
"more",
"than",
"14",
"days",
"prior",
"to",
"registration",
"and",
"must",
"agree",
"to",
"repeat",
"this",
"test",
"within",
"24",
"hours",
"of",
"starting",
"pomalidomide"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02309892
|
10:22:treatment
|
Previous chemotherapy
| 1
|
[
"Previous",
"chemotherapy"
] |
[
0,
1
] |
NCT01504373
|
37:46:chronic_disease
|
Patients who are receiving chemical paralysis
| 1
|
[
"Patients",
"who",
"are",
"receiving",
"chemical",
"paralysis"
] |
[
0,
0,
0,
0,
0,
2
] |
NCT00739362
|
31:40:treatment
|
Right-handedness (because the treatment will be given to the left dorsolateral prefrontal cortex and the evidence accumulated in this region was only in right-handed individuals)
| 1
|
[
"Right-handedness",
"(",
"because",
"the",
"treatment",
"will",
"be",
"given",
"to",
"the",
"left",
"dorsolateral",
"prefrontal",
"cortex",
"and",
"the",
"evidence",
"accumulated",
"in",
"this",
"region",
"was",
"only",
"in",
"right-handed",
"individuals",
")"
] |
[
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02577406
|
22:49:treatment,53:65:treatment,,104:113:treatment
|
Subject has received systemic anticancer therapy or radiotherapy < 14 days prior to the start of study treatment
| 1
|
[
"Subject",
"has",
"received",
"systemic",
"anticancer",
"therapy",
"or",
"radiotherapy",
"<",
"14",
"days",
"prior",
"to",
"the",
"start",
"of",
"study",
"treatment"
] |
[
0,
0,
0,
1,
1,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT01538966
|
23:35:cancer
|
The patient harbors a macroadenoma with visual field defects due to chiasmatic compression
| 1
|
[
"The",
"patient",
"harbors",
"a",
"macroadenoma",
"with",
"visual",
"field",
"defects",
"due",
"to",
"chiasmatic",
"compression"
] |
[
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02555189
|
1:19:treatment
|
Prior chemotherapy
| 1
|
[
"Prior",
"chemotherapy"
] |
[
1,
1
] |
NCT01730118
|
,46:74:treatment
|
Greater than or equal to 6 weeks s/p primary surgery with curative intent
| 1
|
[
"Greater",
"than",
"or",
"equal",
"to",
"6",
"weeks",
"s/p",
"primary",
"surgery",
"with",
"curative",
"intent"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1
] |
NCT02091999
|
15:38:cancer,40:65:cancer,186:205:treatment,251:268:cancer
|
Subjects with nonmelanoma skin cancer, localized prostate cancer treated with curative intent with no evidence of progression, low-risk or very low risk localized prostate cancer under active surveillance/watchful waiting without intent to treat, or carcinoma in situ of any time
| 1
|
[
"Subjects",
"with",
"nonmelanoma",
"skin",
"cancer",
",",
"localized",
"prostate",
"cancer",
"treated",
"with",
"curative",
"intent",
"with",
"no",
"evidence",
"of",
"progression",
",",
"low-risk",
"or",
"very",
"low",
"risk",
"localized",
"prostate",
"cancer",
"under",
"active",
"surveillance/watchful",
"waiting",
"without",
"intent",
"to",
"treat",
",",
"or",
"carcinoma",
"in",
"situ",
"of",
"any",
"time"
] |
[
0,
0,
3,
3,
3,
0,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
0,
0,
0
] |
NCT02519322
|
30:41:chronic_disease,45:46:chronic_disease,64:69:chronic_disease,73:90:chronic_disease
|
Any positive test result for hepatitis B or C virus indicating acute or chronic infection
| 1
|
[
"Any",
"positive",
"test",
"result",
"for",
"hepatitis",
"B",
"or",
"C",
"virus",
"indicating",
"acute",
"or",
"chronic",
"infection"
] |
[
0,
0,
0,
0,
0,
2,
2,
0,
2,
0,
0,
2,
0,
2,
2
] |
NCT02763033
|
52:109:treatment
|
Subjects undergoing matched related full intensity allogeneic HSCT (hematopoietic stem cell transplantation)
| 1
|
[
"Subjects",
"undergoing",
"matched",
"related",
"full",
"intensity",
"allogeneic",
"HSCT",
"(",
"hematopoietic",
"stem",
"cell",
"transplantation",
")"
] |
[
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
1,
1,
0,
0
] |
NCT02706249
|
28:38:chronic_disease,
|
Any history of significant hemorrhage (requiring hospitalization or transfusion) within the last 6 months (excluding hemorrhage during operative procedure)
| 1
|
[
"Any",
"history",
"of",
"significant",
"hemorrhage",
"(",
"requiring",
"hospitalization",
"or",
"transfusion",
")",
"within",
"the",
"last",
"6",
"months",
"(",
"excluding",
"hemorrhage",
"during",
"operative",
"procedure",
")"
] |
[
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01893307
|
11:25:treatment
|
Bilateral Neck Radiation
| 1
|
[
"Bilateral",
"Neck",
"Radiation"
] |
[
0,
1,
1
] |
NCT02553642
|
,68:79:treatment,83:99:treatment,104:118:cancer
|
Subjects with disease recurrence within 1 year of a platinum based neoadjuvant or adjuvant therapy for bladder cancer
| 1
|
[
"Subjects",
"with",
"disease",
"recurrence",
"within",
"1",
"year",
"of",
"a",
"platinum",
"based",
"neoadjuvant",
"or",
"adjuvant",
"therapy",
"for",
"bladder",
"cancer"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
1,
0,
3,
3
] |
NCT02468453
|
16:31:chronic_disease,35:59:chronic_disease,70:97:treatment,,131:140:treatment
|
Having a known anticoagulative or thromboembolic condition or taking anticoagulation medications one week prior to and during the treatment course (to allow inclusion, temporary cessation of use as per the subject's physician discretion)
| 1
|
[
"Having",
"a",
"known",
"anticoagulative",
"or",
"thromboembolic",
"condition",
"or",
"taking",
"anticoagulation",
"medications",
"one",
"week",
"prior",
"to",
"and",
"during",
"the",
"treatment",
"course",
"(",
"to",
"allow",
"inclusion",
",",
"temporary",
"cessation",
"of",
"use",
"as",
"per",
"the",
"subject",
"'s",
"physician",
"discretion",
")"
] |
[
0,
0,
0,
2,
0,
2,
2,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01481974
|
41:68:chronic_disease
|
Those currently receiving treatment for portopulmonary hypertension
| 1
|
[
"Those",
"currently",
"receiving",
"treatment",
"for",
"portopulmonary",
"hypertension"
] |
[
0,
0,
0,
0,
0,
2,
2
] |
NCT02578901
|
54:62:chronic_disease,66:87:chronic_disease,106:129:chronic_disease,131:158:chronic_disease,163:179:chronic_disease,183:200:chronic_disease
|
Subjects with a past history or current diagnosis of arterial or venous thromboembolic disease including acute coronary syndrome, peripheral vascular disease and retinal arterial or venous thrombosis
| 1
|
[
"Subjects",
"with",
"a",
"past",
"history",
"or",
"current",
"diagnosis",
"of",
"arterial",
"or",
"venous",
"thromboembolic",
"disease",
"including",
"acute",
"coronary",
"syndrome",
",",
"peripheral",
"vascular",
"disease",
"and",
"retinal",
"arterial",
"or",
"venous",
"thrombosis"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
2,
2,
0,
0,
2,
2,
2,
0,
2,
2,
2,
0,
2,
2,
0,
0,
0
] |
NCT02266004
|
1:9:chronic_disease
|
dementia
| 1
|
[
"dementia"
] |
[
2
] |
NCT02979327
|
1:11:chronic_disease
|
depression
| 1
|
[
"depression"
] |
[
2
] |
NCT03186872
|
4:17:treatment,
|
No psychotherapy within PCMH within past 6 months including with the psychologist
| 1
|
[
"No",
"psychotherapy",
"within",
"PCMH",
"within",
"past",
"6",
"months",
"including",
"with",
"the",
"psychologist"
] |
[
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02336451
|
28:46:treatment,48:58:treatment,66:80:treatment,99:115:treatment,125:147:treatment
|
Patients may have received prior chemotherapy, crizotinib (other ALK inhibitors are not allowed), biologic therapy or other investigational agents
| 1
|
[
"Patients",
"may",
"have",
"received",
"prior",
"chemotherapy",
",",
"crizotinib",
"(",
"other",
"ALK",
"inhibitors",
"are",
"not",
"allowed",
")",
",",
"biologic",
"therapy",
"or",
"other",
"investigational",
"agents"
] |
[
0,
0,
0,
0,
1,
1,
0,
1,
0,
0,
1,
1,
0,
0,
0,
0,
0,
1,
1,
0,
0,
1,
1
] |
NCT02555280
|
1:22:chronic_disease,,
|
Mild lumbar scoliosis (Cobb angle up to 25º)
| 1
|
[
"Mild",
"lumbar",
"scoliosis",
"(",
"Cobb",
"angle",
"up",
"to",
"25º",
")"
] |
[
2,
2,
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT02516670
|
10:30:treatment,34:59:treatment,,102:112:treatment
|
Have had palliative radiation or biological cancer therapy within 2 weeks prior to the first dose of study drug
| 1
|
[
"Have",
"had",
"palliative",
"radiation",
"or",
"biological",
"cancer",
"therapy",
"within",
"2",
"weeks",
"prior",
"to",
"the",
"first",
"dose",
"of",
"study",
"drug"
] |
[
0,
0,
1,
1,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02131597
|
16:26:cancer
|
Any concurrent malignancy
| 1
|
[
"Any",
"concurrent",
"malignancy"
] |
[
0,
0,
3
] |
NCT01954173
|
30:40:treatment,42:58:treatment,60:78:treatment,83:111:treatment
|
Patients must have undergone cystectomy (total cystectomy, radical cystectomy +/- pelvic lymph node dissection) with no evidence of macroscopic residual disease
| 1
|
[
"Patients",
"must",
"have",
"undergone",
"cystectomy",
"(",
"total",
"cystectomy",
",",
"radical",
"cystectomy",
"+/-",
"pelvic",
"lymph",
"node",
"dissection",
")",
"with",
"no",
"evidence",
"of",
"macroscopic",
"residual",
"disease"
] |
[
0,
0,
0,
0,
1,
0,
1,
1,
0,
1,
1,
0,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03127358
|
14:27:treatment
|
Eligible for HCV treatment per 2016 AASLD/IDSA guidelines
| 1
|
[
"Eligible",
"for",
"HCV",
"treatment",
"per",
"2016",
"AASLD/IDSA",
"guidelines"
] |
[
0,
0,
1,
1,
0,
0,
0,
0
] |
NCT02920788
|
36:39:chronic_disease
|
No history of any (mild to severe) TBI (as defined by DOD / VA; confirmed by medical records and in person Ohio State University TBI Instrument)
| 1
|
[
"No",
"history",
"of",
"any",
"(",
"mild",
"to",
"severe",
")",
"TBI",
"(",
"as",
"defined",
"by",
"DOD",
"/",
"VA",
";",
"confirmed",
"by",
"medical",
"records",
"and",
"in",
"person",
"Ohio",
"State",
"University",
"TBI",
"Instrument",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01760655
|
28:69:treatment,81:84:chronic_disease,107:128:treatment,147:168:treatment
|
Examples are patients with previous treatment with radiation therapy precluding TBI, or a past history of myeloablative therapy, precluding a 2nd myeloablative regimen
| 1
|
[
"Examples",
"are",
"patients",
"with",
"previous",
"treatment",
"with",
"radiation",
"therapy",
"precluding",
"TBI",
",",
"or",
"a",
"past",
"history",
"of",
"myeloablative",
"therapy",
",",
"precluding",
"a",
"2nd",
"myeloablative",
"regimen"
] |
[
0,
0,
0,
0,
1,
1,
1,
1,
1,
0,
2,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0
] |
NCT02890979
|
21:38:cancer,40:54:cancer,58:81:cancer
|
Subjects with known esophageal cancer (adenocarcinoma or squamous cell carcinoma)
| 1
|
[
"Subjects",
"with",
"known",
"esophageal",
"cancer",
"(",
"adenocarcinoma",
"or",
"squamous",
"cell",
"carcinoma",
")"
] |
[
0,
0,
0,
3,
3,
0,
3,
0,
3,
3,
3,
0
] |
NCT02900794
|
1:20:treatment
|
Prior sinus surgery
| 1
|
[
"Prior",
"sinus",
"surgery"
] |
[
1,
1,
1
] |
NCT02106598
|
1:24:treatment,26:38:treatment,43:50:treatment
|
Prior radiation therapy, chemotherapy, or surgery in patients requiring flap reconstruction in the head and neck region
| 1
|
[
"Prior",
"radiation",
"therapy",
",",
"chemotherapy",
",",
"or",
"surgery",
"in",
"patients",
"requiring",
"flap",
"reconstruction",
"in",
"the",
"head",
"and",
"neck",
"region"
] |
[
1,
1,
1,
0,
1,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03181542
|
32:42:treatment
|
Emergency procedures requiring anesthesia
| 1
|
[
"Emergency",
"procedures",
"requiring",
"anesthesia"
] |
[
0,
0,
0,
1
] |
NCT02393794
|
1:20:treatment,22:57:treatment,59:68:treatment,72:84:treatment
|
herapy with heparin, low molecular weight heparin (LMWH), Factor Xa or fondaparinux is allowed
| 1
|
[
"herapy",
"with",
"heparin",
",",
"low",
"molecular",
"weight",
"heparin",
"(",
"LMWH",
")",
",",
"Factor",
"Xa",
"or",
"fondaparinux",
"is",
"allowed"
] |
[
1,
1,
1,
0,
1,
1,
1,
1,
1,
0,
0,
0,
1,
1,
0,
1,
0,
0
] |
NCT01908777
|
11:32:chronic_disease
|
Any known cardiac abnormalities
| 1
|
[
"Any",
"known",
"cardiac",
"abnormalities"
] |
[
0,
0,
2,
2
] |
NCT02053766
|
33:58:chronic_disease
|
Subject has been diagnosed with mitochondrial dysfunction based on modified Walker criteria
| 1
|
[
"Subject",
"has",
"been",
"diagnosed",
"with",
"mitochondrial",
"dysfunction",
"based",
"on",
"modified",
"Walker",
"criteria"
] |
[
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0
] |
NCT01726257
|
6:9:chronic_disease,,
|
Have AAA with sac diameter ≥5.0cm
| 1
|
[
"Have",
"AAA",
"with",
"sac",
"diameter",
"≥5.0cm"
] |
[
0,
2,
0,
0,
0,
0
] |
NCT02803164
|
8:31:chronic_disease
|
Patent bronchopleural fistulas
| 1
|
[
"Patent",
"bronchopleural",
"fistulas"
] |
[
0,
2,
2
] |
NCT02203513
|
38:48:cancer,,115:142:cancer,156:183:cancer,189:225:cancer
|
Another previous or current invasive malignancy within the last 2 years, with the exception of curatively treated stage Ia cervical carcinoma, or resected stage Ia endometrial cancer, and noninvasive nonmelanoma skin cancers
| 1
|
[
"Another",
"previous",
"or",
"current",
"invasive",
"malignancy",
"within",
"the",
"last",
"2",
"years",
",",
"with",
"the",
"exception",
"of",
"curatively",
"treated",
"stage",
"Ia",
"cervical",
"carcinoma",
",",
"or",
"resected",
"stage",
"Ia",
"endometrial",
"cancer",
",",
"and",
"noninvasive",
"nonmelanoma",
"skin",
"cancers"
] |
[
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
3
] |
NCT02514070
|
36:51:chronic_disease,82:101:chronic_disease,103:112:chronic_disease,117:126:chronic_disease
|
Subjects with clinically diagnosed hepatic disease (including but not limited to auto immune disease, hepatitis and cirrhosis)
| 1
|
[
"Subjects",
"with",
"clinically",
"diagnosed",
"hepatic",
"disease",
"(",
"including",
"but",
"not",
"limited",
"to",
"auto",
"immune",
"disease",
",",
"hepatitis",
"and",
"cirrhosis",
")"
] |
[
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
2,
2,
2,
0,
2,
0,
2,
0
] |
NCT03143985
|
,,,85:103:treatment
|
Serum total bilirubin ≤ 2.0 mg/dL or >3.0 x ULN for subjects with hereditary benign hyperbilirubinemia
| 1
|
[
"Serum",
"total",
"bilirubin",
"≤",
"2.0",
"mg/dL",
"or",
">",
"3.0",
"x",
"ULN",
"for",
"subjects",
"with",
"hereditary",
"benign",
"hyperbilirubinemia"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02335905
|
1:22:chronic_disease
|
isseminated infection or is admitted to the pediatric intensive care unit
| 1
|
[
"isseminated",
"infection",
"or",
"is",
"admitted",
"to",
"the",
"pediatric",
"intensive",
"care",
"unit"
] |
[
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02291978
|
103:112:treatment,
|
Individuals who are not able or willing to tolerate the required prolonged stationary position during treatment (can be up to 5 hrs of total table time)
| 1
|
[
"Individuals",
"who",
"are",
"not",
"able",
"or",
"willing",
"to",
"tolerate",
"the",
"required",
"prolonged",
"stationary",
"position",
"during",
"treatment",
"(",
"can",
"be",
"up",
"to",
"5",
"hrs",
"of",
"total",
"table",
"time",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02564744
|
29:51:cancer,53:62:cancer,67:83:cancer,94:110:cancer
|
Participants who have known central nervous system, meningeal, or epidural disease including brain metastases
| 1
|
[
"Participants",
"who",
"have",
"known",
"central",
"nervous",
"system",
",",
"meningeal",
",",
"or",
"epidural",
"disease",
"including",
"brain",
"metastases"
] |
[
0,
0,
0,
0,
3,
3,
3,
0,
3,
0,
0,
3,
3,
0,
3,
3
] |
NCT03122535
|
49:64:treatment
|
Subjects who are deemed suitable candidates for bilateral LASIK will be considered eligible for participation in this study
| 1
|
[
"Subjects",
"who",
"are",
"deemed",
"suitable",
"candidates",
"for",
"bilateral",
"LASIK",
"will",
"be",
"considered",
"eligible",
"for",
"participation",
"in",
"this",
"study"
] |
[
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT00492778
|
3:5:treatment,
|
a CT of the pelvis and abdomen with IV and oral (PO) contrast performed using multi-detector CT and equal or less than 5 mm slice thickness
| 1
|
[
"a",
"CT",
"of",
"the",
"pelvis",
"and",
"abdomen",
"with",
"IV",
"and",
"oral",
"(",
"PO",
")",
"contrast",
"performed",
"using",
"multi-detector",
"CT",
"and",
"equal",
"or",
"less",
"than",
"5",
"mm",
"slice",
"thickness"
] |
[
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02438995
|
,57:62:cancer,149:151:treatment,152:155:treatment,156:164:treatment
|
Patients must have at least one confirmed and evaluable tumor site.* The recurrence must have bidimensional measurements by clinical examination or CT/MRI/PET scan. A confirmed recurrence site may also be biopsy-proven
| 1
|
[
"Patients",
"must",
"have",
"at",
"least",
"one",
"confirmed",
"and",
"evaluable",
"tumor",
"site",
".",
"*",
"The",
"recurrence",
"must",
"have",
"bidimensional",
"measurements",
"by",
"clinical",
"examination",
"or",
"CT/MRI/PET",
"scan",
".",
"A",
"confirmed",
"recurrence",
"site",
"may",
"also",
"be",
"biopsy-proven"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02353728
|
27:37:cancer,
|
History of another active malignancy within 5 years prior to study entry
| 1
|
[
"History",
"of",
"another",
"active",
"malignancy",
"within",
"5",
"years",
"prior",
"to",
"study",
"entry"
] |
[
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0
] |
NCT02942095
|
49:57:treatment
|
Patients that have previously been treated with ixazomib, or participated in a study with ixazomib whether treated with ixazomib or not
| 1
|
[
"Patients",
"that",
"have",
"previously",
"been",
"treated",
"with",
"ixazomib",
",",
"or",
"participated",
"in",
"a",
"study",
"with",
"ixazomib",
"whether",
"treated",
"with",
"ixazomib",
"or",
"not"
] |
[
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02290951
|
,,,82:89:treatment
|
Must have at least one bi-dimensionally measurable lesion ≥1.5 cm) documented by CT scan
| 1
|
[
"Must",
"have",
"at",
"least",
"one",
"bi-dimensionally",
"measurable",
"lesion",
"≥1.5",
"cm",
")",
"documented",
"by",
"CT",
"scan"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02124772
|
12:44:chronic_disease
|
History of heparin-induced thrombocytopenia
| 1
|
[
"History",
"of",
"heparin-induced",
"thrombocytopenia"
] |
[
0,
0,
2,
2
] |
NCT02554903
|
,80:93:treatment
|
negative serum pregnancy test result during the Screening period (Visit 1) and Randomization (Visit 2)
| 1
|
[
"negative",
"serum",
"pregnancy",
"test",
"result",
"during",
"the",
"Screening",
"period",
"(",
"Visit",
"1",
")",
"and",
"Randomization",
"(",
"Visit",
"2",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0
] |
NCT02912572
|
,,42:55:treatment
|
Persisting Grade >=2 toxicity related to prior therapy
| 1
|
[
"Persisting",
"Grade",
">",
"=2",
"toxicity",
"related",
"to",
"prior",
"therapy"
] |
[
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02451423
|
12:41:chronic_disease,43:63:chronic_disease,71:95:chronic_disease,111:122:chronic_disease,124:146:chronic_disease,195:208:treatment
|
History of idiopathic pulmonary fibrosis, organizing pneumonia (e.g., bronchiolitis obliterans), drug-induced pneumonitis, idiopathic pneumonitis, or evidence of active pneumonitis on screening chest CT scan
| 1
|
[
"History",
"of",
"idiopathic",
"pulmonary",
"fibrosis",
",",
"organizing",
"pneumonia",
"(",
"e.g.",
",",
"bronchiolitis",
"obliterans",
")",
",",
"drug-induced",
"pneumonitis",
",",
"idiopathic",
"pneumonitis",
",",
"or",
"evidence",
"of",
"active",
"pneumonitis",
"on",
"screening",
"chest",
"CT",
"scan"
] |
[
0,
0,
2,
2,
2,
0,
2,
2,
0,
0,
0,
2,
2,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1
] |
NCT02800629
|
98:107:chronic_disease,,,,,,,209:232:chronic_disease,,,278:300:chronic_disease
|
While this supplement is considered very safe and low risk, patients with underlying significant cytopenia (white blood cell count less than 4.0, hemoglobin less than 10, or platelets less than 100), or with impaired renal function (glomerular filtration rate less than 60) or elevated liver enzymes will be excluded as well
| 1
|
[
"While",
"this",
"supplement",
"is",
"considered",
"very",
"safe",
"and",
"low",
"risk",
",",
"patients",
"with",
"underlying",
"significant",
"cytopenia",
"(",
"white",
"blood",
"cell",
"count",
"less",
"than",
"4.0",
",",
"hemoglobin",
"less",
"than",
"10",
",",
"or",
"platelets",
"less",
"than",
"100",
")",
",",
"or",
"with",
"impaired",
"renal",
"function",
"(",
"glomerular",
"filtration",
"rate",
"less",
"than",
"60",
")",
"or",
"elevated",
"liver",
"enzymes",
"will",
"be",
"excluded",
"as",
"well"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0
] |
NCT02901041
|
31:43:treatment,45:58:treatment,60:89:treatment,91:100:treatment,106:120:treatment
|
drugs with sulfa moiety (e.g. sulfonamides, sulfonylureas, carbonic anhydrase inhibitors, thiazides, and loop diuretics)
| 1
|
[
"drugs",
"with",
"sulfa",
"moiety",
"(",
"e.g",
".",
"sulfonamides",
",",
"sulfonylureas",
",",
"carbonic",
"anhydrase",
"inhibitors",
",",
"thiazides",
",",
"and",
"loop",
"diuretics",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0,
1,
1,
1,
0,
1,
0,
0,
1,
1,
0
] |
NCT02563678
|
18:30:chronic_disease
|
Co-enrollment in brain injury study
| 1
|
[
"Co-enrollment",
"in",
"brain",
"injury",
"study"
] |
[
0,
0,
2,
2,
0
] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.